• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global lymphoma treatment market grew at a CAGR of around 8% during 2015-2020. Lymphoma refers to a type of cancer characterized by the rapid development of abnormal malignant cells in the lymphatic system. It usually targets the white blood cells (WBCs), or lymphocytes, in lymph nodes, spleen, thymus and bone marrow and impairs the immune response of the body. As a result, the patient develops swelling in the lymph nodes, high fever, weight loss, dyspnea and fatigue. Some of the commonly used lymphoma therapeutics include radiation, chemo and monoclonal antibody therapy, active surveillance, bone marrow transplant and immunotherapy drugs. These therapeutics are widely used for the treatment of both Hodgkin and non-Hodgkin lymphoma.

The increasing prevalence of non-Hodgkin lymphoma across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. In line with this, the increasing awareness among the masses regarding the available diagnostic technologies and treatment alternatives for lymphoma is also creating a positive outlook for the market. Hospitals and other diagnostic centers are using innovative tests and imaging technologies, such as computed tomography (CT), Magnetic Resonance Imaging (MRI) and positron emission tomography (PET) scans, for accurate identification of the cancer cells and timely treatment. Additionally, various technological advancements, including the development of innovative immune checkpoint inhibitors, which block proteins from binding together and increase the response strength of T-cells against cancer cells, are contributing to the market growth. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with overall improvements in the healthcare infrastructure, are anticipated to drive the market further. Looking forward, IMARC Group expects the global lymphoma treatment market to continue its moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global lymphoma treatment market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type, test type and drug.

Breakup by Type:

  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
     

Breakup by Test Type:

  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Targeted Therapy
  • Biologic Therapy
  • Others
     

Breakup by Drug:

  • Adcetris
  • Rituxan
  • Opdivo
  • Imbruvica
  • Keytruda
  • Revlimid
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Spectrum Pharmaceuticals, Takeda Pharmaceutical Company Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global lymphoma treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lymphoma treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the drug?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lymphoma treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Lymphoma Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Hodgkin Lymphoma
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Non-Hodgkin Lymphoma
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Test Type
    7.1    Chemotherapy
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Radiation Therapy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunotherapy
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Targeted Therapy
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Biologic Therapy
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Drug
    8.1    Adcetris
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Rituxan
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Opdivo
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Imbruvica
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Keytruda
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Revlimid
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
            9.1.1.1 Market Trends
            9.1.1.2 Market Forecast
        9.1.2 Canada
            9.1.2.1 Market Trends
            9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
            9.2.1.1 Market Trends
            9.2.1.2 Market Forecast
        9.2.2 Japan
            9.2.2.1 Market Trends
            9.2.2.2 Market Forecast
        9.2.3 India
            9.2.3.1 Market Trends
            9.2.3.2 Market Forecast
        9.2.4 South Korea
            9.2.4.1 Market Trends
            9.2.4.2 Market Forecast
        9.2.5 Australia
            9.2.5.1 Market Trends
            9.2.5.2 Market Forecast
        9.2.6 Indonesia
            9.2.6.1 Market Trends
            9.2.6.2 Market Forecast
        9.2.7 Others
            9.2.7.1 Market Trends
            9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
            9.3.1.1 Market Trends
            9.3.1.2 Market Forecast
        9.3.2 France
            9.3.2.1 Market Trends
            9.3.2.2 Market Forecast
        9.3.3 United Kingdom
            9.3.3.1 Market Trends
            9.3.3.2 Market Forecast
        9.3.4 Italy
            9.3.4.1 Market Trends
            9.3.4.2 Market Forecast
        9.3.5 Spain
            9.3.5.1 Market Trends
            9.3.5.2 Market Forecast
        9.3.6 Russia
            9.3.6.1 Market Trends
            9.3.6.2 Market Forecast
        9.3.7 Others
            9.3.7.1 Market Trends
            9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
            9.4.1.1 Market Trends
            9.4.1.2 Market Forecast
        9.4.2 Mexico
            9.4.2.1 Market Trends
            9.4.2.2 Market Forecast
        9.4.3 Others
            9.4.3.1 Market Trends
            9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
            14.3.1.1 Company Overview
            14.3.1.2 Product Portfolio
            14.3.1.3 Financials
            14.3.1.4 SWOT Analysis
        14.3.2    Bristol-Myers Squibb Company
            14.3.2.1 Company Overview
            14.3.2.2 Product Portfolio
            14.3.2.3 Financials
            14.3.2.4 SWOT Analysis
        14.3.3    Eli Lilly and Company
            14.3.3.1 Company Overview
            14.3.3.2 Product Portfolio
            14.3.3.3 Financials
            14.3.3.4 SWOT Analysis
        14.3.4    F. Hoffmann-La Roche Ltd.
            14.3.4.1 Company Overview
            14.3.4.2 Product Portfolio
            14.3.4.3 SWOT Analysis
        14.3.5    Johnson & Johnson
            14.3.5.1 Company Overview
            14.3.5.2 Product Portfolio
            14.3.5.3 Financials
            14.3.5.4 SWOT Analysis
        14.3.6    Merck & Co. Inc.
            14.3.6.1 Company Overview
            14.3.6.2 Product Portfolio
            14.3.6.3 Financials
            14.3.6.4 SWOT Analysis
        14.3.7    Novartis AG
            14.3.7.1 Company Overview
            14.3.7.2 Product Portfolio
            14.3.7.3 Financials
            14.3.7.4 SWOT Analysis
        14.3.8    Spectrum Pharmaceuticals
            14.3.8.1 Company Overview
            14.3.8.2 Product Portfolio
            14.3.8.3 Financials
            14.3.8.4 SWOT Analysis
        14.3.9    Takeda Pharmaceutical Company Ltd.
            14.3.9.1 Company Overview
            14.3.9.2 Product Portfolio
            14.3.9.3 Financials
            14.3.9.4 SWOT Analysis
        14.3.10    Teva Pharmaceutical Industries Ltd.
            14.3.10.1 Company Overview
            14.3.10.2 Product Portfolio
            14.3.10.3 Financials
            14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Lymphoma Treatment Market: Major Drivers and Challenges
Figure 2: Global: Lymphoma Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Lymphoma Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Lymphoma Treatment Market: Breakup by Type (in %), 2020
Figure 5: Global: Lymphoma Treatment Market: Breakup by Test Type (in %), 2020
Figure 6: Global: Lymphoma Treatment Market: Breakup by Drug (in %), 2020
Figure 7: Global: Lymphoma Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Lymphoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Lymphoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Lymphoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Lymphoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Lymphoma Treatment (Immunotherapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Lymphoma Treatment (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Lymphoma Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Lymphoma Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Lymphoma Treatment (Biologic Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Lymphoma Treatment (Biologic Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Lymphoma Treatment (Other Test Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Lymphoma Treatment (Other Test Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Lymphoma Treatment (Adcetris) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Lymphoma Treatment (Adcetris) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Lymphoma Treatment (Rituxan) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Lymphoma Treatment (Rituxan) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Lymphoma Treatment (Opdivo) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Lymphoma Treatment (Opdivo) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Lymphoma Treatment (Imbruvica) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Lymphoma Treatment (Imbruvica) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Lymphoma Treatment (Keytruda) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Lymphoma Treatment (Keytruda) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Lymphoma Treatment (Revlimid) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Lymphoma Treatment (Revlimid) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Lymphoma Treatment (Other Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Lymphoma Treatment (Other Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: North America: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: North America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: United States: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: United States: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Canada: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Canada: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Asia-Pacific: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Asia-Pacific: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: China: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: China: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Japan: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Japan: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: India: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: India: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: South Korea: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: South Korea: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Australia: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Australia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Indonesia: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Indonesia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Europe: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Europe: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Germany: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Germany: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: France: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: France: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: United Kingdom: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: United Kingdom: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Italy: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Italy: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Spain: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Spain: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Russia: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Russia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Latin America: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Latin America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Brazil: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Brazil: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Mexico: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Mexico: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Middle East and Africa: Lymphoma Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Middle East and Africa: Lymphoma Treatment Market: Breakup by Country (in %), 2020
Figure 86: Middle East and Africa: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Global: Lymphoma Treatment Industry: SWOT Analysis
Figure 88: Global: Lymphoma Treatment Industry: Value Chain Analysis
Figure 89: Global: Lymphoma Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Lymphoma Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Lymphoma Treatment Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Lymphoma Treatment Market Forecast: Breakup by Test Type (in Million US$), 2021-2026
Table 4: Global: Lymphoma Treatment Market Forecast: Breakup by Drug (in Million US$), 2021-2026
Table 5: Global: Lymphoma Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Lymphoma Treatment Market: Competitive Structure
Table 7: Global: Lymphoma Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links